Chanxpress, Inc.

Cleveland, OH 44128

SBIR Award Summary

Total Number of Awards 5
Total Value of Awards $1.5MM
First Award Date 02/01/04
Most Recent Award Date 08/01/06

Key Personnel

Last Name Name Awards Contact
Ficker Eckhard K Ficker 1
Wible Barbara A Wible 4

5 Awards Won

Phase 2 SBIR

Agency: Department of Health & Human Services
Topic:
Budget: 08/01/06 - 07/31/07

DESCRIPTION (provided by applicant): Ion channels comprise 10-20 percent of known drug targets for diseases including cardiac arrhythmias, stroke, hypertension, heart failure, asthma, cystic fibrosis, epilepsy, migraine, mental disorders, muscular dystrophy, and cancer. While ion channels provide important therapeutic targets, they are often th...

Phase 2 SBIR

Agency: Department of Health & Human Services
Topic:
Budget: 09/09/05 - 07/31/06

DESCRIPTION (provided by applicant): Ion channels comprise 10-20 percent of known drug targets for diseases including cardiac arrhythmias, stroke, hypertension, heart failure, asthma, cystic fibrosis, epilepsy, migraine, mental disorders, muscular dystrophy, and cancer. While ion channels provide important therapeutic targets, they are often th...

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic: PA-02-75
Budget: 04/01/05 - 03/31/06

DESCRIPTION (provided by applicant): The major goal of the proposed research is to develop a novel high throughput method for evaluating the cardiac liability of anticancer drugs. In recent years, more and more adverse cardiac events have been linked to the use of non-cardiac drugs. An important example of an anticancer drug with this associa...

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic: PA-02-75
Budget: 04/19/04 - 03/31/05

DESCRIPTION (provided by applicant): The major goal of the proposed research is to develop a novel high throughput method for evaluating the cardiac liability of anticancer drugs. In recent years, more and more adverse cardiac events have been linked to the use of non-cardiac drugs. An important example of an anticancer drug with this associa...

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic:
Budget: 02/01/04 - 07/31/04

DESCRIPTION (provided by applicant): Ion channels comprise 10-20 percent of known drug targets for diseases including cardiac arrhythmias, stroke, hypertension, heart failure, asthma, cystic fibrosis, epilepsy, migraine, mental disorders, muscular dystrophy, and cancer. While ion channels provide important therapeutic targets, they are often the...